Stay updated on Open-Label Surufatinib in EU NET Patients Clinical Trial
Sign up to get notified when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.

Latest updates to the Open-Label Surufatinib in EU NET Patients Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5. This reflects a maintenance update to the page.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing v3.6.3. This indicates a minor update to the page's documentation/versioning rather than changes to the study content.SummaryDifference0.0%

- Check50 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3, indicating a new version of the document. The update records the revision change in the page metadata.SummaryDifference0.0%

- Check57 days agoChange DetectedA new revision tag 'Revision: v3.6.2' appears on the page, indicating an update to the page version/history rather than a change to study details.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page now indicates that the study is no longer enrolling participants. New sections How to Read a Study Record, Common Questions, and How to Join a Study were added, the Intervention/Treatment label was updated, and the revision is now v3.6.0.SummaryDifference0.5%

- Check78 days agoChange DetectedRevision: v3.5.5 appears on the page, replacing the previous v3.5.4. This indicates a small platform update that does not change the study details or results presented.SummaryDifference0.0%

Stay in the know with updates to Open-Label Surufatinib in EU NET Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.